InfertilityNCT02639715
Morphometrics and Morphokinetics of Thawed Oocytes and Embryos
An observational study of Infertility, run by Sophie Debrock.
Trial summary
The aim of this observational study is to describe for the first time a complete set of morphometric and morphokinetic parameters of frozen-thawed human embryos in order to select the embryo with the highest implantation potential. Read more about this study
- Who is it for?
- Ages 18 to 40 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Infertility
- How many people
- 1,272 participants
- Where
- No sites listed yet
- Study dates
- Jan 2014to Dec 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- Women only
- Healthy volunteers accepted
- Adult
Study population: Patients with frozen thawed embryos for an ART treatment cycle
Who may be able to join
- patients with female age < 40 years at Oocyte retrieval
Who cannot join
- Patients with female age >40 years at Oocyte retrieval
- cycles with Preimplantation genetic diagnosis
- donated gametes
About this study
The aim of this observational study is to describe for the first time a complete set of morphometric and morphokinetic parameters of frozen-thawed human embryos in order to select the embryo with the highest implantation potential. These parameters will be correlated with (1) data of the fresh embryos and their subsequent survival, the evolution of the contact surfaces between surviving blastomeres and the resumption of mitosis; (2) patient characteristics and clinical outcome of frozen-thawed embryos and (3) a comparison between embryos cryopreserved with vitrification or the slow method regarding these parameters will be performed.
This project aims to introduce new evaluation criteria of the frozen-thawed embryos to improve success rate of FET cycles. By establishing new precise, reliable and non-invasive measurable parameters, we aim to (1) select which supernumerary embryos are at chance to survive the freezing/thawing procedures, (2) establish cut off parameters for the survival rate of the embryo, (3) assess implantation, pregnancy and live birth rates depending on the developmental characteristics after thawing and after 24h of culture.
Our strategy for improving the outcome of FET cycles is based on the study of morphometric and morphokinetic parameters in frozen-thawed embryos and the correlation with embryological, clinical and cycle parameters. Transferring a well-defined thawed embryo with a high implantation potential may lead towards an increase in the implantation and life birth rate and an increase in the cumulative live birth rate with a reduction of the IVF costs in order to optimize the health-economic situation of reproductive medicine.
Read the detailed description
Cryopreservation of supernumerary embryos is an essential part of Assisted Reproduction Techniques (ART) and is nowadays a standard routine procedure in the IVF laboratory. Its clinical application consists in (1) the possibility of increasing cumulative delivery rates per cycle and (2) the reduction of the number of transferable embryos in both fresh and successive frozen thawed embryo transfer cycles (FET) decreasing the risk of multiple pregnancies.
Two different techniques to cryopreserve embryos are commonly used: slow freezing and vitrification. During slow freezing, the embryo is exposed to subzero temperatures in a controlled rate with the use of low concentration of cryoprotectant. Alternatively, using vitrification the embryo rapidly enters into a glass-like state with the use of high concentrations of cryoprotectant and rapid cooling rates. Several studies comparing cryopreservation of human embryos by vitrification or slow freezing are available and meta-analyses have been published. Although vitrification has been found to have significantly higher survival rates than slow freezing, results on implantation rate, clinical pregnancy rate and live birth rate remain unclear, mostly due to a paucity of well-designed and powered prospective randomized controlled studies assessing live birth rates.
Embryo evaluation to select the embryo(s) with the highest implantation potential is routinely based on embryo developmental and morphological characteristics using light microscopy. The embryo parameters usually correlated to the implantation capacity of an embryo in a fresh cycle are the number of blastomeres, their symmetry and the percentage cytoplasmic fragmentation. For the evaluation of frozen-thawed embryos, the percentage of blastomeres that survive the freezing-thawing process and their developmental capacity after overnight culture have to be added to these factors.
Current research in the development of non-invasive methods for scoring embryos and ranking them according to their ability to implant and give rise to a healthy birth include both morphometrics and morphokinetics.
Morphometrics Multilevel computerized images enable assessment over an unlimited time period and allow a detailed evaluation of the embryo. Several morphometric studies of human fresh oocytes and embryos with embryo implantation and development have been published. Morphometric studies using multilevel images combined with a computer-assisted scoring system (CASS) may be superior compared to standard scoring system (SSS) to predict implantation and/or live birth based on the number and size of blastomeres on day 3. Semi-automated morphometric analysis also revealed correlations between total embryo volume and clinical pregnancy. Another study evaluating morphometric characteristics including the absolute volumes, coefficients of form and the coefficient of diversity of human embryos and/or oocytes showed a higher coefficient of diversity between sister blastomeres in embryos that successfully implanted and progressed to birth. Morphometric characteristics including the external and internal diameter of the zona pellucida, the thickness of the zona pellucida and the embryo cell mass diameter were described. They stated that image analysis could be used to predict the criteria needed for more efficient embryo assessment before transfer. The mean blastomere size was correlated with the degree of fragmentation and multinucleation in a study using computer-controlled multilevel analyses with 232 embryos. However, until now, no morphometric studies in human frozen thawed embryos have been described.
Morphokinetics Time-lapse imaging allows documentation of early growth without disturbing the culture environment. At this moment, no prospective randomized trial data are available showing that embryos selected from time-lapse imaging have significantly improved implantation rates compared with embryos selected with conventional morphological evaluation.
However, time lapse imaging of embryos have revealed a correlation between first cleavage time, time between cleavages, blastomere size and multinucleation and implantation potential of human embryos. A correlation between the times of each embryo cleavage between 2 to 8 cell stage, the ability to become a blastocyst and implantation potential. Moreover, morphokinetic studies have demonstrated that direct cleavage from 2 cells to 3 cells has been correlated with a low implantation and ongoing pregnancy rate. According to time-lapse recording in 38 oocytes, embryo quality was related to fertilization events and periodicity of the cyctoplasmic wave: good quality embryos arose from oocytes that had more uniform timing from injection to pronuclear abuttal and longer cytoplasmic wave. Furthermore, cellular fragments in human embryos can disappear during in vitro culture.
Only a few studies on morphokinetics in human cryopreserved embryos have been published. Using videocinematography on respectively 50 and 103 frozen-thawed embryos, it was shown that the occurrence of smooth membranes and the cell-cell adherence were predictive for the implantation capacity of frozen-cleaved embryos. Wong et al. followed the development of 242 supernumerary frozen d1-old embryos in a study combining time lapse microscopy and gene expression profiling: success in progression to the blastocyst stage could be predicted by measuring three dynamic, noninvasive imaging parameters by day 2 after fertilization before embryonic genome activation: (1) duration of the first cytokinesis, (2) time interval between the end of the first mitosis and the initiation of the second and (3) the time interval between the second and third mitoses.
This observational study aims to describe morphometric and morphokinetic parameters of thawed human embryos after freezing (slow freezing or vitrification). The study will focus on the evolution of the blastomere volume, the evolution of the contact surfaces between surviving blastomeres and the development of the embryo using time lapse imaging. Embryo morphometric and morphokinetic parameters will be analyzed together with patient characteristics and clinical parameters using cluster analysis techniques. The correlation between morphometrics/morphokinetics and the implantation potential of frozen-thawed embryos will be studied in cycles with single embryo transfer and in cycles with dual implantation after double embryo transfer.
- Conditions
- Infertility
- Medical subject headings
- Infertility
What is being measured
The primary outcome is the main question the study is designed to answer.
embryo implantation (measured by the number of intrauterine fetal sacs on ultrasound per number of embryos transferred) after a thawing / warming cycle
Measured: 6-7 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Dec 2015 (estimated)
- Study startJan 2014
- Primary completionDec 2014
- Study completionDec 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for InfertilityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 1,272 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sophie Debrock
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Sophie Debrock, KU Leuven
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02639715
- Sponsor's protocol ID
- S55685
- Status last verified
- Dec 2015
- First submitted
- 15 Dec 2015
- Last updated
- 24 Dec 2015
- Results posted
- No
- Data monitoring committee
- No
Publications
Fernandez Gallardo E, Spiessens C, D'Hooghe T, Debrock S. Effect of day 3 embryo morphometrics and morphokinetics on survival and implantation after slow freezing-thawing and after vitrification-warming: a retrospective cohort study. Reprod Biol Endocrinol. 2017 Oct 3;15(1):79. doi: 10.1186/s12958-017-0299-5.
PubMed 28974230Fernandez Gallardo E, Spiessens C, D'Hooghe T, Debrock S. Effect of embryo morphology and morphometrics on implantation of vitrified day 3 embryos after warming: a retrospective cohort study. Reprod Biol Endocrinol. 2016 Jul 30;14(1):40. doi: 10.1186/s12958-016-0175-8.
PubMed 27475526
Study at a glance
From the registry record, last updated by the sponsor on 24 Dec 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Morphometrics and Morphokinetics of Thawed Oocytes and Embryos
- ClinicalTrials.gov ID
- NCT02639715
- Acronym / sponsor ID
- S55685
- Conditions
- Infertility
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,272 participants (actual)
- Lead sponsor
- Sophie DebrockUniversity, hospital or other
- Study start
- Jan 2014
- Primary completion
- Dec 2014 (actual)
- Study completion
- Dec 2015 (actual)
- First posted
- 24 Dec 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this observational study is to describe for the first time a complete set of morphometric and morphokinetic parameters of frozen-thawed human embryos in order to select the embryo with the highest implantation potential. These parameters will be correlated with (1) data of the fresh embryos and their subsequent survival, the evolution of the contact surfaces between surviving blastomeres and the resumption of mitosis; (2) patient characteristics and clinical outcome of frozen-thawed embryos and (3) a comparison between embryos cryopreserved with vitrification or the slow method regarding these parameters will be performed.
This project aims to introduce new evaluation criteria of the frozen-thawed embryos to improve success rate of FET cycles. By establishing new precise, reliable and non-invasive measurable parameters, we aim to (1) select which supernumerary embryos are at chance to survive the freezing/thawing procedures, (2) establish cut off parameters for the survival rate of the embryo, (3) assess implantation, pregnancy and live birth rates depending on the developmental characteristics after thawing and after 24h of culture.
Our strategy for improving the outcome of FET cycles is based on the study of morphometric and morphokinetic parameters in frozen-thawed embryos and the correlation with embryological, clinical and cycle parameters. Transferring a well-defined thawed embryo with a high implantation potential may lead towards an increase in the implantation and life birth rate and an increase in the cumulative live birth rate with a reduction of the IVF costs in order to optimize the health-economic situation of reproductive medicine.
Detailed description
Cryopreservation of supernumerary embryos is an essential part of Assisted Reproduction Techniques (ART) and is nowadays a standard routine procedure in the IVF laboratory. Its clinical application consists in (1) the possibility of increasing cumulative delivery rates per cycle and (2) the reduction of the number of transferable embryos in both fresh and successive frozen thawed embryo transfer cycles (FET) decreasing the risk of multiple pregnancies.
Two different techniques to cryopreserve embryos are commonly used: slow freezing and vitrification. During slow freezing, the embryo is exposed to subzero temperatures in a controlled rate with the use of low concentration of cryoprotectant. Alternatively, using vitrification the embryo rapidly enters into a glass-like state with the use of high concentrations of cryoprotectant and rapid cooling rates. Several studies comparing cryopreservation of human embryos by vitrification or slow freezing are available and meta-analyses have been published. Although vitrification has been found to have significantly higher survival rates than slow freezing, results on implantation rate, clinical pregnancy rate and live birth rate remain unclear, mostly due to a paucity of well-designed and powered prospective randomized controlled studies assessing live birth rates.
Embryo evaluation to select the embryo(s) with the highest implantation potential is routinely based on embryo developmental and morphological characteristics using light microscopy. The embryo parameters usually correlated to the implantation capacity of an embryo in a fresh cycle are the number of blastomeres, their symmetry and the percentage cytoplasmic fragmentation. For the evaluation of frozen-thawed embryos, the percentage of blastomeres that survive the freezing-thawing process and their developmental capacity after overnight culture have to be added to these factors.
Current research in the development of non-invasive methods for scoring embryos and ranking them according to their ability to implant and give rise to a healthy birth include both morphometrics and morphokinetics.
Morphometrics Multilevel computerized images enable assessment over an unlimited time period and allow a detailed evaluation of the embryo. Several morphometric studies of human fresh oocytes and embryos with embryo implantation and development have been published. Morphometric studies using multilevel images combined with a computer-assisted scoring system (CASS) may be superior compared to standard scoring system (SSS) to predict implantation and/or live birth based on the number and size of blastomeres on day 3. Semi-automated morphometric analysis also revealed correlations between total embryo volume and clinical pregnancy. Another study evaluating morphometric characteristics including the absolute volumes, coefficients of form and the coefficient of diversity of human embryos and/or oocytes showed a higher coefficient of diversity between sister blastomeres in embryos that successfully implanted and progressed to birth. Morphometric characteristics including the external and internal diameter of the zona pellucida, the thickness of the zona pellucida and the embryo cell mass diameter were described. They stated that image analysis could be used to predict the criteria needed for more efficient embryo assessment before transfer. The mean blastomere size was correlated with the degree of fragmentation and multinucleation in a study using computer-controlled multilevel analyses with 232 embryos. However, until now, no morphometric studies in human frozen thawed embryos have been described.
Morphokinetics Time-lapse imaging allows documentation of early growth without disturbing the culture environment. At this moment, no prospective randomized trial data are available showing that embryos selected from time-lapse imaging have significantly improved implantation rates compared with embryos selected with conventional morphological evaluation.
However, time lapse imaging of embryos have revealed a correlation between first cleavage time, time between cleavages, blastomere size and multinucleation and implantation potential of human embryos. A correlation between the times of each embryo cleavage between 2 to 8 cell stage, the ability to become a blastocyst and implantation potential. Moreover, morphokinetic studies have demonstrated that direct cleavage from 2 cells to 3 cells has been correlated with a low implantation and ongoing pregnancy rate. According to time-lapse recording in 38 oocytes, embryo quality was related to fertilization events and periodicity of the cyctoplasmic wave: good quality embryos arose from oocytes that had more uniform timing from injection to pronuclear abuttal and longer cytoplasmic wave. Furthermore, cellular fragments in human embryos can disappear during in vitro culture.
Only a few studies on morphokinetics in human cryopreserved embryos have been published. Using videocinematography on respectively 50 and 103 frozen-thawed embryos, it was shown that the occurrence of smooth membranes and the cell-cell adherence were predictive for the implantation capacity of frozen-cleaved embryos. Wong et al. followed the development of 242 supernumerary frozen d1-old embryos in a study combining time lapse microscopy and gene expression profiling: success in progression to the blastocyst stage could be predicted by measuring three dynamic, noninvasive imaging parameters by day 2 after fertilization before embryonic genome activation: (1) duration of the first cytokinesis, (2) time interval between the end of the first mitosis and the initiation of the second and (3) the time interval between the second and third mitoses.
This observational study aims to describe morphometric and morphokinetic parameters of thawed human embryos after freezing (slow freezing or vitrification). The study will focus on the evolution of the blastomere volume, the evolution of the contact surfaces between surviving blastomeres and the development of the embryo using time lapse imaging. Embryo morphometric and morphokinetic parameters will be analyzed together with patient characteristics and clinical parameters using cluster analysis techniques. The correlation between morphometrics/morphokinetics and the implantation potential of frozen-thawed embryos will be studied in cycles with single embryo transfer and in cycles with dual implantation after double embryo transfer.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 to 40 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Patients with frozen thawed embryos for an ART treatment cycle
Key inclusion criteria (1 listed)
- patients with female age < 40 years at Oocyte retrieval
Key exclusion criteria (3 listed)
- Patients with female age >40 years at Oocyte retrieval
- cycles with Preimplantation genetic diagnosis
- donated gametes
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
embryo implantation (measured by the number of intrauterine fetal sacs on ultrasound per number of embryos transferred) after a thawing / warming cycle
Time frame: 6-7 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Dec 2015.
- Derived from this study: PubMed 28974230Fernandez Gallardo E, Spiessens C, D'Hooghe T, Debrock S. Effect of day 3 embryo morphometrics and morphokinetics on survival and implantation after slow freezing-thawing and after vitrification-warming: a retrospective cohort study. Reprod Biol Endocrinol. 2017 Oct 3;15(1):79. doi: 10.1186/s12958-017-0299-5.
- Derived from this study: PubMed 27475526Fernandez Gallardo E, Spiessens C, D'Hooghe T, Debrock S. Effect of embryo morphology and morphometrics on implantation of vitrified day 3 embryos after warming: a retrospective cohort study. Reprod Biol Endocrinol. 2016 Jul 30;14(1):40. doi: 10.1186/s12958-016-0175-8.
Related trials for Infertility
RecruitingPhase 3
A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)
Infertility
Active, not recruitingObservational study
Fresh Versus Vitrified-Warmed Donor Oocytes: Embryological and Clinical Outcomes
Infertility, Donor Oocyte Assisted Reproduction
RecruitingObservational study
Safety and Efficacy of Corifollitropin Alfa N02 Injection in Elderly Women Undergoing Assisted Reproductive Technology (ART)
Infertility
Active, not recruiting
Automation of the In Vitro Fertilization Laboratory
Infertility, ART
Not yet recruiting
Implementing IVM for Fertility Treatment in Clinical Practice
Infertility
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Infertility, run by Sophie Debrock.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 Dec 2015. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
embryo implantation (measured by the number of intrauterine fetal sacs on ultrasound per number of embryos transferred) after a thawing / warming cycle (time frame: 6-7 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02639715, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2015.